NEW DRUG-PROTEIN CONJUGATES AND ANTIBODY IMMUNOCONJUGATES FOR TARGETED THERAPY AND DIAGNOSIS.
Summary: New drugs have been spotted to design and produce drug-protein conjugates, drug-antibody conjugates and other immunoconjugates to many useful bioactive molecules such as monoclonal antibodies and their derivatives.
Fields of the invention: Therapy and diagnosis of cancer and other diseases, biotechnology, pharmacology, immunology, etc.
We are looking for development partners.
MONOCLONAL ANTIBODY INDEX and VACCINE ANTIGEN INDEX
ALGORIMUT©: MUTATION PREDICTION ALGORITHM
QUANTITATIVE SINGLE-CELL PROTEOMICS
NEW BIOMARKER DISCOVERY AND IDENTIFICATION SYSTEM.